Aptabio Therapeutics Inc. (293780)
Market Open
7 Aug, 06:30
KRX SM KRX SM Primary ₩
5,570. 00
-290
-4.9488%
₩
227.15B Market Cap
- P/E Ratio
- Div Yield
61,586 Volume
- Eps
₩ 5,860
Previous Close Want to track 293780 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aptabio Therapeutics Inc. (293780) Statistics
Valuation metrics
Market Cap 227.15B
Enterprise value 153.32B
Trailing P/E (ttm) -7.42
Forward P/E -
PEG ratio -0.24
Price/Sales (ttm) 36.63
Price/Book (mrq) 3.67
Enterprise Value/Revenue 35.89
Enterprise Value/EBITDA -8.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 83.71K
Average volume (90 days) 101.84K
Price summary
52-Week low 3,870
52-Week high 10,890
Beta -
50-Day moving average 4,548.86
200-Day moving average 6,452.44
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 24 Aug 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.73%
Operating margin -4.44%
Operational effectiveness
Return on assets -0.38%
Return on equity -0.45%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 158.74
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -750.99
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 320.41
Total debt (mrq) -
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 1.72%
Book value per share (mrq) 1,519.52
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
